Manulife reported 2Q2023 annualised premium equivalent (APE) sales of HK$2.10bn ($269m) in Hong Kong and Macau, China's two Special Administrative Regions.
If you are already a subscriber
OR sign-up for a trial access here
Note that your comment may be edited or removed in the future, and that your comment may appear alongside the original article on websites other than this one.
more »
Brought to you by